Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Dec 12;18(1):189.
doi: 10.1186/s12871-018-0651-0.

Cell salvage using the continuous autotransfusion device CATSmart - an observational bicenter technical evaluation

Affiliations
Multicenter Study

Cell salvage using the continuous autotransfusion device CATSmart - an observational bicenter technical evaluation

Simone Lindau et al. BMC Anesthesiol. .

Abstract

Background: The use of cell salvage and autologous blood transfusion has become an important method of blood conservation. So far, there are no clinical data about the performance of the continuous autotransfusion device CATSmart.

Methods: In total, 74 patients undergoing either cardiac or orthopedic surgery were included in this prospective, bicenter and observational technical evaluation to validate red cell separation process and washout quality of CATSmart. The target of red cell separation process was defined as a hematocrit value in the packed red cell unit of 55-75% and of washout quality of 80-100% removal ratio.

Results: Hematocrit values measured by CATSmart and laboratory analysis were 78.5% [71.3%; 84.0%] and 73.7% [67.5%; 75.5%], respectively. Removal ratios for platelets 94.7% [88.2%; 96.7%], free hemoglobin 89.3% [85.2%; 94.9%], albumin 97.9% [96.6%; 98.5%], heparin 99.9% [99.9%; 100.0%], and potassium 92.5% [90.8%; 95.0%] were within the target range while removal of white blood cells was slightly worse 72.4% [57.9%; 87.3%].

Conclusion: The new autotransfusion device enables sufficient red cell separation and washout quality.

Keywords: Auto transfusion; Cell salvage; Hematocrit value.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The ethics committee of the University Hospital Frankfurt approved the protocol addressing patients undergoing cardiac surgery (approval ref. 80/15). A written consent of the participations was not required according to national regulations (German Constitution Art. 72, Berufsordnung für Ärzte §15, HeilBerG Nordrhein-Westfalen §7). This technical evaluation was not required and thus not submitted to IRB of the Marienhospital Bottrop (Ärztekammer Westfalen Lippe) according to regional and national regulations (German Constitution Art. 72, Berufsordnung für Ärzte §15, HeilBerG Nordrhein-Westfalen §7).

Consent for publication

Not applicable.

Competing interests

PM and KZ received grants from B. Braun Melsungen, CSL Behring, Fresenius Kabi, and Vifor Pharma for the implementation of Frankfurt‘s Patient Blood Management program and honoraria for scientific lectures from B. Braun Melsungen, Vifor Pharma, Fearing, CSL Behring, and Pharmacosmos.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Flowchart of participants
Fig. 2
Fig. 2
Red cell separation performance defined by hematocrit values. Data are presented as median [25%;75%]. Hematocrit (Hct) values are shown before (IN, shed blood) and after blood processing (OUT, packed red cells) by central laboratory (LAB) and CATSmart.
Fig. 3
Fig. 3
Hematocrit values in RBC concentrates. Hct values of the packed red cell concentrate measured by CATSmart and the laboratory (LAB) significantly correlated (r = 0.51; p ≤ 0.05).
Fig. 4
Fig. 4
Washout quality defined by removal ratio (%) of multiple blood parameters for each of the 50 analyzed patients. WBC = white blood cells; Plt = platelets; Alb = albumin; fHb = free hemoglobin; aXa = heparin; K+ = potassium.

References

    1. Meybohm P, Choorapoikayil S, Wessels A, Herrmann E, Zacharowski K, Spahn DR. Washed cell salvage in surgical patients: a review and meta-analysis of prospective randomized trials under PRISMA. Medicine (Baltimore) 2016;95:e4490. doi: 10.1097/MD.0000000000004490. - DOI - PMC - PubMed
    1. Alberts M, Groom RC, Walczak R, Kramer R, Karpiel A, Dieter J, et al. In vitro evaluation of the Fresenius Kabi CATSmart autotransfusion system. J Extra Corpor Technol. 2017;49:107–111. - PMC - PubMed
    1. Fresenius Kabi. CATSmart - https://www.fresenius-kabi.com/in/products/catsmart. 22.10.2018.
    1. Seyfried TF, Gruber M, Bitzinger D, Pawlik MT, Breu A, Graf BM, Hansen E. Performance of a new-generation continuous autotransfusion device including fat removal and consequences for quality controls. Transfus Med. 2017;27:292–299. doi: 10.1111/tme.12421. - DOI - PubMed
    1. Bundesärztekammer. Richtlinie zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Richtlinie Hämotherapie);17.02.2017.

Publication types